• LAST PRICE
    160.4800
  • TODAY'S CHANGE (%)
    Trending Down-1.4900 (-0.9199%)
  • Bid / Lots
    160.5200/ 1
  • Ask / Lots
    161.0000/ 2
  • Open / Previous Close
    168.3900 / 161.9700
  • Day Range
    Low 156.0000
    High 169.0000
  • 52 Week Range
    Low 106.1100
    High 331.6800
  • Volume
    4,509,467
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Line Graph See accessible table below
News Volume Accessibility Table
DateIndex Fund Price vs. News Density
11/4$179.41
11/5$159.19
11/8$173.02
11/9$169.30
11/10$164.19
11/11$169.38
11/12$169.89
11/15$172.45
11/16$170.49
11/17$183.99
11/18$191.05
11/19$192.34
11/22$207.99
11/23$200.71
11/24$200.07
11/26$217.97
11/29$193.96
11/30$208.63
12/1$192.65
12/2$161.97
12/3$160.48

1 hour ago by Accesswire
Companies Mentioned: NVAX

RADNOR, PA / ACCESSWIRE / December 4, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Novavax, Inc. ("Novavax") (NASDAQ:NVAX). The action charges Novavax with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Novavax's materially misleading statements, Novavax investors have suffered significant losses.

12 hours ago by GlobeNewswire
Companies Mentioned: NVAX

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) in the United States District Court for the Southern District of Maryland on behalf of all persons and entities who purchased or otherwise acquired Novavax securities between March 2, 2021 and October 19, 2021, both dates inclusive (the "Class Period"). Investors have until January 11, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

4:16PM ET on Friday Dec 03, 2021 by Business Wire
Companies Mentioned: NVAX

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Novavax, Inc. (NASDAQ: NVAX) between March 2, 2021 and October 19, 2021, inclusive (the "Class Period"), of the important January 11, 2022 lead plaintiff deadline.

3:37PM ET on Friday Dec 03, 2021 by Newsfile
Companies Mentioned: NVAX

New York, New York--(Newsfile Corp. - December 3, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Novavax, Inc. ("Novavax") (NASDAQ: NVAX) between March 2, 2021 and October 19, 2021.

2:04PM ET on Friday Dec 03, 2021 by Newsfile
Companies Mentioned: NVAX

Los Angeles, California--(Newsfile Corp. - December 3, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novavax, Inc. ("Novavax" or "the Company") (NASDAQ: NVAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Peers Headlines

Today

Yesterday

Dec 2, 2021